Protecting muscle on GLP-1: lose fat, not muscle.

How much muscle do you actually lose on a GLP-1?

• Semaglutide — STEP-1 DXA substudy (140 participants): over 68 weeks, body weight fell 15.0% versus 3.6% on placebo. Total fat mass dropped 19.3% and lean body mass dropped 9.7% — about 10.4kg fat and 6.9kg lean, a roughly 60% fat / 40% lean split.
• Tirzepatide — SURMOUNT-1 DXA substudy (160 participants): over 72 weeks, body weight fell 21.3%, fat mass 33.9%, and lean mass 10.9% — about 75% fat / 25% lean, consistent across age and sex.
• The reassuring nuance: because fat falls faster than muscle, lean mass as a proportion of body weight actually rises (in STEP-1, by about 3 percentage points), and the tirzepatide fat-to-lean ratio improved from 0.93 to 0.70. Body composition improves overall; the concern is the absolute kilos of muscle lost — especially in people who started with little.

A later analysis in Circulation (Prado et al., 2024) put it in absolute terms: about 45.5% of the weight lost on semaglutide in STEP-1 was lean mass, and about 34.3% on tirzepatide in SURMOUNT-1. One note of caution: "lean mass" on a DXA includes water, glycogen and organ tissue — so true contractile-muscle loss is a fraction of these numbers.

Why does muscle loss happen — and is it the drug's fault?

A recent systematic review even concluded GLP-1 receptor agonists may preserve muscle quality (reduced fat infiltration) as total lean mass declines, and meta-analyses haven't found clinically meaningful loss of grip strength or function — though trials in adults over 65 are largely missing. The honest summary: losing some muscle when shedding a large body is partly appropriate; the problem is when the loss is disproportionate, when you were already low on muscle, or when it tips an older adult below the threshold for independence.

Why are Indians especially at risk?

• Chronic protein deficiency. The average Indian eats ~0.6g protein/kg/day against the ICMR-NIN 2020 RDA of 0.83 (which was itself lowered from 1g/kg). The 2017 IMRB study found 73% of Indian diets are protein-deficient and 93% of Indians don't know their protein requirement, with 84% of vegetarian versus 65% of non-vegetarian diets falling short. Indian diets draw ~65–75% of calories from carbohydrate and only ~9–11% from protein.
• The "thin-fat" Asian-Indian phenotype. Indians carry more body and visceral fat and less skeletal muscle than Europeans at any given BMI. A multi-city study found 71% of Indians aged 30–55 have poor muscle health — highest in Lucknow (81%), lowest in Delhi (64%).
• High diabetes burden. An estimated 101 million Indians have diabetes (ICMR-INDIAB, Lancet Diabetes & Endocrinology, 2023), and high blood sugar itself accelerates muscle loss — so many GLP-1 users start with a head-start toward sarcopenia.

If you eat a vegetarian diet, this is doubly true — and our vegetarian protein guide does the gram math on hitting 90–100g a day from Indian food.

How much protein do I need to protect muscle?

Because a GLP-1 suppresses appetite, the protein has to be deliberately front-loaded into smaller meals. Distributing it evenly across 3–4 meals builds more daily muscle than the typical Indian pattern of a protein-light breakfast and a big dinner. Indian protein anchors, per 100g unless noted: low-fat paneer ~20g; dry soya chunks ~52g (higher than chicken breast); soya chaap ~15g; chana/rajma ~14–15g per cooked cup; dal ~8–10g per cooked cup; Greek/hung curd ~10g; one egg ~6g; chicken breast ~31g; whey ~24g per scoop. Whey is vegetarian (it's milk protein) and is the most practical way to hit targets when appetite is low; liquid protein (smoothies, lassi, sattu) is better tolerated during nausea-heavy titration weeks.

Strength training: the non-negotiable signal

• Frequency: 2–3 sessions/week, full-body, with a rest day between. Going from zero to two sessions matters far more than two to three.
• Exercises: compound movements working multiple muscle groups — squats, lunges, push-ups, rows, overhead press, deadlifts (or band/machine equivalents).
• Dose: 2–3 sets of 8–12 reps, last rep challenging but with good form; add weight or reps over time.
• Equipment for India: a gym is ideal, but resistance bands (a few hundred rupees online), bodyweight exercises and household weights all provide adequate stimulus — important, since India's organised-fitness penetration is still under 1%.
• Realistic goal: during a steep deficit the aim is preservation, not growth. Building muscle becomes feasible at a maintenance dose or after the weight-loss phase.

Creatine, bone health and supplements

Creatine monohydrate, 3–5g/day, has a strong safety record and supports training intensity and lean-mass retention in a deficit — no loading needed. Bone matters too: rapid weight loss reduces mechanical loading on bone and, with low calcium, vitamin D and protein, can lower bone density; the semaglutide label notes possible increased fracture risk in older adults and women. Resistance and weight-bearing exercise plus adequate protein, calcium and vitamin D protect bone as well as muscle. Highest-risk groups: post-menopausal women, adults over 50, and anyone losing weight very fast. Because vitamin D and B12 deficiency are near-universal in India, it's worth tracking them — see which blood tests to run before and during a GLP-1.

Why this matters beyond aesthetics: weight regain

The stakes are concrete: in the SURMOUNT-4 trial, switching tirzepatide to placebo led to regaining an average of 14% of body weight, and in the STEP-1 extension participants regained about two-thirds of their loss within a year of stopping. The defence against that body-composition damage is the same protein-and-training habit you build now — which is exactly why a maintenance plan for coming off Mounjaro leans so heavily on muscle. And if your scale has simply stalled mid-journey, muscle loss is one of the five causes worth ruling out in our plateau guide.

Your staged muscle-protection plan

Stage 0 — before or at the start (titration weeks). Get a baseline: weight, waist, and if accessible a DXA or bio-impedance scan and a handgrip test (re-check composition every 3–4 months, not the scale daily). Set your protein target now — bodyweight in kg × 1.2–1.6 — and buy whey and stock soya/paneer/dal before appetite drops. Start resistance training before big appetite suppression hits.

Stage 1 — active weight-loss phase. Protein first at every meal (25–30g × 3–4 meals), using shakes/lassi/sattu when nausea makes solids hard. Resistance train 2–3×/week; add 3–5g creatine. Don't lose too fast — sustained loss faster than ~1% body weight/week increases muscle and bone loss. If loss is very rapid and you feel weak, ask your prescriber about a slower titration or a lower maintenance dose.

Stage 2 — maintenance / coming off. Keep the protein and training habits — they're what prevent the body-composition damage of regain. The benchmarks that should change your plan: grip strength dropping below about 28kg for men or 18kg for women, trouble rising from a chair, new falls, or measured lean-mass loss exceeding ~25% of total weight lost → escalate protein, add supervised resistance training, slow the loss rate, and review with your clinician.

How Kaivo protects your muscle

Kaivo's program is built so you lose fat, not muscle. Our founding physicians, Dr. Rinku Sarmah and Dr. Harshit Anand, set a protein target and a resistance-training plan from day one, our dietitians make it work on Indian (and vegetarian or Jain) food, and our blood panels track vitamin D, B12 and ferritin so weakness and hair fall get caught early. Medication is bought separately at a licensed pharmacy with no Kaivo markup — so the advice stays about your health.

1. Wilding JPH et al. STEP-1 and DXA body-composition substudy. NEJM 2021.
2. Look M et al. SURMOUNT-1 body-composition substudy. Diabetes, Obesity & Metabolism 2025.
3. Prado CM et al. Lean-mass loss with semaglutide and tirzepatide. Circulation 2024.
4. Anjana RM et al. ICMR-INDIAB-17 national diabetes prevalence. Lancet Diabetes & Endocrinology 2023.
5. ICMR-NIN. Recommended Dietary Allowances for Indians, revised 2020.
6. IMRB. Understanding Protein Myths & Gaps among Indians, 2017.
7. Asian Working Group for Sarcopenia (AWGS) 2019 consensus on diagnosis and cut-offs.